Abstract
Introduction Previous studies have suggested that smoking and drinking alcohol are prostate cancer risks. However, how regional unevenness of radiation oncologists/urologists in Japan or other risk factors including social background correlate with age-adjusted mortality of prostate cancer remain unknown.
Methods In addition to known factors like smoking, we examined whether various other factors, such as the regional unevenness of radiotherapists/urologists, correlated with age-adjusted mortality rate (AAMR) for prostate cancer by prefecture. Statistical data were obtained from Annual Report of Hospital-Based Cancer Registries, Comprehensive Survey of Living Conditions and etc. We used the 10-year averages of AAMR from 2009 to 2018 in each prefecture to determine mortality rates.
Results There was no correlation between the number of radiation oncologists/urologists per 100,000 and the 10-year averages of AAMR by prefecture in Japan. On the other hand, smoking rates and drinking per capita were correlated, respectively (P = 0.0002 and 0.0008).
Conclusion The current study of statistics by prefecture in Japan also suggests that factors such as smoking and drinking alcohol are correlated with the risk of prostate cancer mortality. On the other hand, regional unevenness of radiation oncologists did not correlate. These results suggest that there is validity in this study design of analyzing factors of risk of prostate cancer mortality. And the study design was suggested to be useful for comparing various patient background factors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This was an epidemiological study. The IRB approval was waved.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Availability of data and materials The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
